INCOME STATEMENT
Bliss GVS Pharma Ltd.
BSE
Jun 04
133.25
+0.25 (+ 0.19%)
Volume
24547
Prev. Close
133.00
Open Price
133.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 04
132.96
-0.20 ( -0.15%)
Volume
204355
Prev. Close
133.16
Open Price
133.80
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE416D01022
|
Market Cap. ( ₹ in Cr. )
|
1401.00
|
P/BV
|
1.39
|
Book Value ( ₹ )
|
95.85
|
BSE Code
|
506197
|
52 Week High/Low ( ₹ )
|
186/92
|
FV/ML
|
1/1
|
P/E(X)
|
16.62
|
NSE Code
|
BLISSGVSEQ
|
Book Closure
|
25/07/2024
|
EPS ( ₹ )
|
8.00
|
Div Yield (%)
|
0.38
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 667.20 | 601.98 | 595.59 | 627.73 | 459.25 |
Other Operating Revenues | 0.00 | 3.48 | 2.75 | 8.63 | 6.26 |
Total Operating Revenues | 667.20 | 605.46 | 598.34 | 636.36 | 465.51 |
| | | | | |
Other Income | 36.22 | 33.50 | 50.77 | 32.63 | 17.68 |
Total Revenue | 703.42 | 638.96 | 649.11 | 668.98 | 483.20 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 339.47 | 305.83 | 293.66 | 350.83 | 215.65 |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 2.01 | 46.50 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 6.63 | -6.36 | 21.24 | -8.90 | -8.85 |
Employee Benefit Expenses | 99.42 | 82.59 | 72.54 | 65.06 | 58.61 |
Finance Costs | 6.58 | 5.81 | 10.06 | 4.32 | 4.19 |
Depreciation And Amortisation Expenses | 27.05 | 23.52 | 15.17 | 13.85 | 13.76 |
Other Expenses | 130.09 | 116.23 | 120.74 | 118.16 | 62.14 |
Total Expenses | 609.25 | 527.62 | 533.41 | 545.33 | 392.01 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 94.17 | 111.34 | 115.69 | 123.66 | 91.19 |
| | | | | |
Exceptional Items | 0.00 | -41.09 | 0.00 | 2.75 | 0.00 |
Profit/Loss Before Tax | 94.17 | 70.26 | 115.69 | 126.40 | 91.19 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 25.20 | 26.34 | 34.42 | 31.92 | 21.52 |
Deferred Tax | 0.00 | -7.55 | -4.21 | 0.77 | 1.17 |
Tax For Earlier Years | 0.00 | 0.83 | 0.00 | 1.05 | 0.99 |
Total Tax Expenses | 25.20 | 19.61 | 30.21 | 33.74 | 23.69 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 68.97 | 50.64 | 85.48 | 92.66 | 67.50 |
| | | | | |
Profit/Loss From Continuing Operations | 68.97 | 50.64 | 85.48 | 92.66 | 67.50 |
| | | | | |
Profit/Loss For The Period | 68.97 | 50.64 | 85.48 | 92.66 | 67.50 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 6.56 | 4.85 | 8.23 | 8.97 | 6.54 |
Diluted EPS (Rs.) | 6.50 | 4.77 | 8.10 | 8.81 | 6.40 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 5.21 | 5.19 | 5.18 | 5.16 |
Equity Dividend Rate (%) | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |